Navigation Links
Sequenom Announces Participation at Jefferies 2011 Global Healthcare Conference
Date:5/26/2011

SAN DIEGO, May 26, 2011 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM)), a life sciences company providing innovative genetic analysis solutions, today announced the Company's participation at the Jefferies 2011 Global Healthcare Conference at the Grand Hyatt Hotel in New York City, June 6-9, 2011.

(Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO)

Harry F. Hixson, Jr., Ph.D., Chairman and CEO will present on Wednesday, June 8, 2011 beginning at 1:30 p.m. EDT, to provide an overview of and update on the Company. The presentation is expected to last approximately 30 minutes and will be web cast live through the "Investors" section of the Sequenom website at www.sequenom.com. An audio replay will be available for 30 days following the initial presentation web cast.

About Sequenom

Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a website at http://www.sequenom.com to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom website to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

SEQUENOM ® is a trademark of Sequenom, Inc. All other trademarks and service marks are the property of their respective owners.


'/>"/>
SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sequenom Announces Publication Acceptance of Manuscript From Age-related Macular Degeneration Validation Study
2. Sequenom Announces Publication Acceptance of Manuscript From Trisomy 21 R&D Verification Study
3. Sequenom Announces Exercise in Full of Underwriters Option to Purchase Additional Shares
4. Sequenom Announces Formation of Ophthalmology Clinical Advisory Board
5. Sequenom to Present at Two Financial Conferences in September
6. Sequenom to Present at Two Financial Conferences in March
7. Sequenom Appoints Two New Board Members
8. SEQUENOM Announces Partnership With GeneWorks for Sales & Marketing of MassARRAY Systems and Applications in Australia
9. SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
10. SEQUENOM Announces Launch of MassARRAY Compact 96 System
11. SEQUENOM to Hold First Quarter 2009 Financial Results Conference Call on April 30
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017 According to ... products and derivatives market is fragmented due to the presence of a ... as Proliant, Thermo Fisher , and Sigma-Aldrich, compete with each ... three companies, collectively, held more than 76% of this market in ... As of ...
(Date:3/22/2017)... N.Y. , March 22, 2017 Regeneron Pharmaceuticals, ... the Regeneron Genetics Center (RGC), U.K. Biobank and GSK to ... the U.K. Biobank resource. The initiative will enable researchers to ... new medicines for a wide range of serious and life ... ...
(Date:3/22/2017)... 2017 Good Start Genetics, a leading family ... 130 million covered lives mark through its most recent ... Texas . With newly signed contracts nationally and ... strong payor acceptance based on the quality of its ... counseling, its industry-leading customer care and support and its ...
(Date:3/22/2017)... Florida , March 22, 2017 ... ... various cancer conditions are being pressured as of late due ... for cancer pain management has a dramatic impact on patient,s ... research and development activities for identifying new forms of opioid ...
Breaking Biology Technology:
(Date:3/24/2017)... , March 24, 2017 The Controller General ... Controller Mr. Abdulla Algeen have received the prestigious international IAIR ... Continue Reading ... ... picture) and Deputy Controller Abdulla Algeen (small picture on the right) have ...
(Date:3/24/2017)... DUBLIN , Mar 24, 2017 Research ... Vehicle Access System Market Analysis & Trends - Industry Forecast to ... ... poised to grow at a CAGR of around 15.1% over the ... This industry report analyzes the market estimates and forecasts for ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and ... 2022", published by MarketsandMarkets, the market is expected to be worth USD 18.98 ... Continue Reading ... ...      ...
Breaking Biology News(10 mins):